Your browser doesn't support javascript.
loading
Opportunities and challenges in the development of experimental drug combinations for cancer.
Humphrey, Rachel W; Brockway-Lunardi, Laura M; Bonk, David T; Dohoney, Kathleen M; Doroshow, James H; Meech, Sandra J; Ratain, Mark J; Topalian, Suzanne L; Pardoll, Drew M.
Affiliation
  • Humphrey RW; Global Development, Bristol-Myers Squibb Company, Princeton, NJ, USA.
J Natl Cancer Inst ; 103(16): 1222-6, 2011 Aug 17.
Article in En | MEDLINE | ID: mdl-21765011
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Clinical Trials as Topic / Molecular Targeted Therapy / Neoplasms Type of study: Guideline / Prognostic_studies Limits: Animals / Humans Country/Region as subject: America do norte Language: En Journal: J Natl Cancer Inst Year: 2011 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Clinical Trials as Topic / Molecular Targeted Therapy / Neoplasms Type of study: Guideline / Prognostic_studies Limits: Animals / Humans Country/Region as subject: America do norte Language: En Journal: J Natl Cancer Inst Year: 2011 Document type: Article Affiliation country: Estados Unidos